Profile | GDS2987 / GI_6912611-A |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 102.3 | 77 |
GSM215244 | HMVEC_vehicle_rep2 | 68.1 | 72 |
GSM215253 | HMVEC_vehicle_rep3 | 91.8 | 76 |
GSM215254 | HMVEC_atorvastatin_rep1 | 156.4 | 80 |
GSM215282 | HMVEC_atorvastatin_rep3 | 141.1 | 79 |
GSM215344 | HMVEC_atorvastatin_rep2 | 108.6 | 76 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 127.9 | 78 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 76.7 | 72 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 80.4 | 72 |
GSM215294 | HMVEC_SLx2119_rep1 | 122 | 79 |
GSM215295 | HMVEC_SLx2119_rep2 | 124.9 | 77 |
GSM215296 | HMVEC_SLx2119_rep3 | 124 | 77 |
GSM215297 | PASMC_vehicle_rep1 | 85.9 | 71 |
GSM215298 | PASMC_vehicle_rep2 | 65.4 | 66 |
GSM215310 | PASMC_vehicle_rep3 | 98 | 74 |
GSM215311 | PASMC_atorvastatin_rep1 | 135.9 | 77 |
GSM215312 | PASMC_atorvastatin_rep2 | 113.6 | 75 |
GSM215313 | PASMC_atorvastatin_rep3 | 88.1 | 72 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 166.7 | 79 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 111.4 | 75 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 126.8 | 76 |
GSM215327 | PASMC_SLx2119_rep1 | 98.4 | 74 |
GSM215328 | PASMC_SLx2119_rep2 | 45.6 | 61 |
GSM215329 | PASMC_SLx2119_rep3 | 77 | 72 |
GSM215330 | Fibroblasts_vehicle_rep1 | 2.8 | 7 |
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 23.8 | 57 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 1.3 | 4 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 5.6 | 19 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 0.2 | 0 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 5.6 | 16 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 4.7 | 14 |
GSM215340 | Fibroblasts_SLx2119_rep2 | ||
GSM215341 | Fibroblasts_SLx2119_rep3 | 2.1 | 5 |